Evolva establishes sales office in Singapore

4 August 2016 – Evolva (SIX: EVE) has set up in Singapore, with a focus on commercial operations to develop sales and support customers in the Asia-Pacific region.

Customers that can benefit from our ingredients (currently resveratrol, nootkatone and valencene) include food and beverage, nutrition, flavour & fragrance, personal care, household product, animal health and insect control companies.

“Our Singapore presence allows us to tap into the dynamic Asia-Pacific region more extensively than we can today. We have encountered significant interest in Asia and have decided a local presence makes sense. Singapore offers an excellent infrastructure and connections into the region as well as supportive local institutions.” said Evolva’s Chief Commercial Officer Luc Gruner.

– ends –

Download press release in English
Download press release in German

About Evolva

Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com. Questions about our fermentation approach? Have a look at our video.

Contact Details

Neil Goldsmith
+ 41 61 485 2005
Jakob Dynnes Hansen
+ 41 61 485 2034
Paul Verbraeken
+ 41 61 485 2035

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.